6/26/2019  6:00:22 PM Chg. -2.63 Volume Bid- Ask6:00:45 PM Market Capitalization Dividend Y. P/E Ratio
245.61USD -1.06% 9,200
Turnover: 2.26 mill.
-Bid Size: - 245.76Ask Size: 100 66.95 bill.USD 1.21% 400.35

Business description

BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. The innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes.

Management board & Supervisory board

Vincent A. Forlenza
Management board
Christopher R. Reidy, Alberto Mas, Alexandre Conroy, James Lim, James W. Borzi, John P. Groetelaars, Nabil Shabshab, Roland Goette, Samrat S. Khichi, Thomas Polen
Supervisory board
Vincent A. Forlenza, Bertram L. Scott, Catherine M. Burzik, Christopher Jones, Claire M. Fraser, Claire Pomeroy, David F. Melcher, Gary A. Mecklenburg, Marshall O. Larsen, R. Andrew Eckert, Rebecca W. Rimel, Timothy M. Ring, Willard J. Overlock, Jr.

Company data

Name: Becton, Dickinson and Company
Address: 1 Becton Drive,Franklin Lakes, New Jersey 07414, USA
Phone: +1-201-847-6800
Fax: -
E-mail: -
Internet: www.bd.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 9/30
Free Float: 64.60%
IPO date: -

Investor relations

Name: Monique N. Dolecki
IR phone: +1-201-847-5378
IR-Fax: -
IR e-mail: monique_dolecki@bd.com

Company calendar

CW 26 | 6/28/2019 Dividend Payment

Main Shareholders

T. Rowe Price Associates, Inc.
The Vanguard Group, Inc.
BlackRock, Inc.